MA50371A - Procédé de préparation de dérivés spiro - Google Patents

Procédé de préparation de dérivés spiro

Info

Publication number
MA50371A
MA50371A MA050371A MA50371A MA50371A MA 50371 A MA50371 A MA 50371A MA 050371 A MA050371 A MA 050371A MA 50371 A MA50371 A MA 50371A MA 50371 A MA50371 A MA 50371A
Authority
MA
Morocco
Prior art keywords
preparation process
derivative preparation
spiro derivative
spiro
preparation
Prior art date
Application number
MA050371A
Other languages
English (en)
French (fr)
Inventor
Thierry Bonnaud
Richard Edwards
Gerard M P Giblin
David T Macpherson
Osama Suleiman
Michael Williams
David R Witty
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of MA50371A publication Critical patent/MA50371A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10Salicylic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Volume Flow (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
MA050371A 2017-10-10 2018-10-10 Procédé de préparation de dérivés spiro MA50371A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762570269P 2017-10-10 2017-10-10

Publications (1)

Publication Number Publication Date
MA50371A true MA50371A (fr) 2021-03-31

Family

ID=66100090

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050371A MA50371A (fr) 2017-10-10 2018-10-10 Procédé de préparation de dérivés spiro

Country Status (12)

Country Link
US (2) US11149039B2 (https=)
EP (1) EP3694510A4 (https=)
JP (1) JP2020536898A (https=)
KR (1) KR20200068678A (https=)
CN (1) CN111526874A (https=)
AU (1) AU2018347349A1 (https=)
CA (1) CA3077088A1 (https=)
IL (1) IL273695A (https=)
MA (1) MA50371A (https=)
MX (2) MX2020003821A (https=)
SG (1) SG11202002707VA (https=)
WO (1) WO2019075073A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3077088A1 (en) 2017-10-10 2019-04-18 Biogen Inc. Process for preparing spiro derivatives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US814396A (en) 1905-05-22 1906-03-06 Joseph R Russell Burner for liquid fuel.
KR0178475B1 (ko) 1995-09-14 1999-03-20 윤덕용 신규한 n-비닐락탐 유도체 및 그의 중합체
WO2004005293A2 (en) 2002-07-05 2004-01-15 Targacept, Inc. N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
US7501528B2 (en) 2005-03-15 2009-03-10 Hoffmann-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
US8143306B2 (en) 2005-10-10 2012-03-27 Convergence Pharmaceuticals Limited Methods of treating bipolar disorders
GB0520578D0 (en) 2005-10-10 2005-11-16 Glaxo Group Ltd Novel compounds
TW200730494A (en) 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
ATE472529T1 (de) 2005-10-10 2010-07-15 Glaxo Group Ltd Prolinamidderivate als natriumkanalmodulatoren
JP2010506853A (ja) 2006-10-12 2010-03-04 ゼノン・ファーマシューティカルズ・インコーポレイテッド 疼痛などのナトリウムチャネル媒介性の疾患の処置のための、スピロ([3,2−フロ]ピリジン−3,3’−インドール)−2’(1’h)−オン誘導体および関連化合物
AU2007307635A1 (en) 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
GB0701365D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0701366D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0706630D0 (en) 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
JP5855000B2 (ja) 2009-09-14 2016-02-09 クオンベルゲンセ プハルマセウトイカルス リミテッド α−カルボキサミド誘導体の製造方法
US8618303B2 (en) 2011-01-07 2013-12-31 Hoffmann-La Roche Inc. Pyrrolidine derivatives
PL2702051T3 (pl) * 2011-04-26 2015-08-31 Hoffmann La Roche Pochodne etynylu jako pozytywne allosteryczne modulatory mglur5
GB201122113D0 (en) 2011-12-22 2012-02-01 Convergence Pharmaceuticals Novel compounds
GB201209015D0 (en) * 2012-05-22 2012-07-04 Convergence Pharmaceuticals Novel compounds
GB201209670D0 (en) 2012-05-31 2012-07-18 Convergence Pharmaceuticals Novel compounds
JP6619420B2 (ja) 2014-08-04 2019-12-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Metap−2阻害剤としてのピロリジノン誘導体
EP3687533A4 (en) 2017-09-28 2021-01-20 Biogen Inc. NEW SALT
CA3077088A1 (en) 2017-10-10 2019-04-18 Biogen Inc. Process for preparing spiro derivatives

Also Published As

Publication number Publication date
JP2020536898A (ja) 2020-12-17
MX2020003821A (es) 2023-01-12
US20220033408A1 (en) 2022-02-03
WO2019075073A3 (en) 2020-04-02
EP3694510A2 (en) 2020-08-19
MX2022013928A (es) 2022-11-30
WO2019075073A2 (en) 2019-04-18
US20200325144A1 (en) 2020-10-15
US11149039B2 (en) 2021-10-19
IL273695A (en) 2020-05-31
CA3077088A1 (en) 2019-04-18
KR20200068678A (ko) 2020-06-15
SG11202002707VA (en) 2020-04-29
AU2018347349A1 (en) 2020-04-23
CN111526874A (zh) 2020-08-11
EP3694510A4 (en) 2021-06-30

Similar Documents

Publication Publication Date Title
MA54253A (fr) Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines
EP3398960A4 (en) METHOD FOR PRODUCING SERMAGLUTIDE
EP3312240A4 (en) METHOD OF PREPARING POLYCARBONATE RESIN COMPOSITION
EP3434262A4 (en) PROCESS FOR PREPARING MICROGRANULATE WITH DELAYED RELEASE
EP3556769A4 (en) POLYMYXINE DERIVATIVE, MANUFACTURING PROCESS AND APPLICATION OF IT
MA49472A (fr) Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole
EP3694499A4 (en) NEW PROCESS FOR MANUFACTURING LIFITEGRAST
EP3597674A4 (en) METHOD FOR PRODUCING COPOLYMER
EP3500551A4 (en) METHOD FOR PREPARING SUBSTITUTED BIPHENYLE
MA50517A (fr) Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole
EP3766869A4 (en) SIMPLE MANUFACTURING PROCESS FOR AVIBACTAM
EP3400197A4 (en) IMPROVED METHOD FOR THE PRODUCTION OF ISOSULFAN BLUE
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
EP3539941A4 (en) PROCESS FOR THE PREPARATION OF TRIMETHYLOLPROPANE
EP3504221A4 (en) INNOVATIVE PROCESS FOR THE PRODUCTION OF CORTICOSTEROIDS
EP3696168A4 (en) PROCESS FOR THE PREPARATION OF 2-CHLORO-5-TRIFLUOROMETHYLPYRIDINE
EP3511313A4 (en) METHOD FOR PRODUCING 1,3-CYCLOHEXANDIMETHANOL
EP3350154A4 (en) IMPROVED METHOD FOR THE PRODUCTION OF A TRIENTINDIHYDROCHLORIDE
EP3647304A4 (en) PROCESS FOR THE PRODUCTION OF 2-FLUOROACRYLATE
EP3444253A4 (en) PROCESS FOR PREPARING AD-35
EP3455210A4 (en) PROCESS FOR THE PREPARATION OF BOSCALID
EP3733651A4 (en) METHOD FOR MANUFACTURING CALCOBUTROL
EP3770239A4 (en) MANUFACTURING METHOD FOR MICROCAPSULES
EP3359512A4 (en) PROCESS FOR THE PREPARATION OF ORGANIC BROMIDES
EP3727377A4 (en) PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDS